News

Study: Most oncologists don’t discuss exercise with patients


 

Fitness class

Results of a small, single-center study suggest oncologists may not provide cancer patients with adequate guidance on exercise.

A majority of the patients and oncologists surveyed for this study placed importance on exercise during cancer care, but most of the oncologists failed to give patients recommendations on exercise.

“Our results indicate that exercise is perceived as important to patients with cancer, both from a patient and physician perspective,” said study author Agnes Smaradottir, MD, of Gundersen Health System in La Crosse, Wisconsin.

“However, physicians are reluctant to consistently include [physical activity] recommendations in their patient discussions.”

Dr Smaradottir and her colleagues reported these findings in JNCCN.

The researchers surveyed 20 cancer patients and 9 oncologists for this study.

The patients’ mean age was 64. Ten patients had stage I-III non-metastatic cancer after adjuvant therapy, and 10 had stage IV metastatic disease and were undergoing palliative treatment. Most patients had solid tumor malignancies, but 1 had chronic lymphocytic leukemia.

The oncologists’ mean age was 45, 56% were male, and they had a mean of 12 years of practice. Most (89%) said they exercise on a regular basis.

Discussions

Nineteen (95%) of the patients surveyed felt they benefited from exercise during treatment, but only 3 of the patients recalled being instructed to exercise.

Exercise was felt to be an equally important part of treatment and well-being for patients with early stage cancer treated with curative intent as well as patients receiving palliative therapy.

Although all the oncologists noted that exercise can benefit cancer patients, only 1 of the 9 surveyed documented discussion of exercise in patient charts.

Preferences and concerns

More than 80% of the patients said they would prefer a home-based exercise regimen that could be performed in alignment with their personal schedules and symptoms.

Patients also noted a preference that exercise recommendations come from their oncologists, as they have an established relationship and feel their oncologists best understand the complexities of their personalized treatment plans.

The oncologists, on the other hand, wanted to refer patients to specialist care for exercise recommendations. Reasons for this included the oncologists’ mounting clinic schedules and a lack of education about appropriate physical activity recommendations for patients.

The oncologists also expressed concern about asking patients to be more physically active during chemotherapy and radiation and expressed trepidation about prescribing exercise to frail patients with limited mobility.

“We were surprised by the gap in expectations regarding exercise recommendation between patients and providers,” Dr Smaradottir said. “Many providers, ourselves included, thought patients would prefer to be referred to an exercise center, but they clearly preferred to have a home-based program recommended by their oncologist.”

“Our findings highlight the value of examining both patient and provider attitudes and behavioral intentions. While we uncovered barriers to exercise recommendations, questions remain on how to bridge the gap between patient and provider preferences.”

Recommended Reading

Cord blood/placental cell combo induces rapid immune recovery
MDedge Hematology and Oncology
High CD86+pDC counts may predict CML relapses
MDedge Hematology and Oncology
Could refractory T-ALL be daratumumab’s next frontier?
MDedge Hematology and Oncology
MRD better measure of ALL remission than morphology
MDedge Hematology and Oncology
Videos reduce need for anesthesia in kids undergoing radiotherapy
MDedge Hematology and Oncology
Drug elicits responses in MDS patients
MDedge Hematology and Oncology
Novel inhibitor proves ‘potent’ in hematologic malignancies
MDedge Hematology and Oncology
BTK inhibitor staves off progression in CLL
MDedge Hematology and Oncology
Study shows similar outcomes with RIC and MAC in MDS
MDedge Hematology and Oncology
Formaldehyde probably doesn’t cause leukemia, team says
MDedge Hematology and Oncology